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P h o sp h o ry la se  k in a se  is a  m u ltim e ric  p ro te in  k in ase  
(a 4p 4y 484) w h o se e n zym atic  a c tiv ity  is c o n fe rre d  b y  its  
y-su b u n it. A  lib r a r y  o f 18  o v e rla p p in g  sy n th e tic  p ep tid e s  
sp a n n in g  re sid u e s 2 7 7 -3 8 6  o f th e y-su b u n it h a s been  
p re p a r e d  to u se  in  id e n tify in g  im p o rta n t re g u la to ry  
stru c tu re s  in  th e p ro tein . In  th e  p re se n t stu d y, th e li ­
b r a r y  w a s  scre e n e d  to id e n tify  re g io n s th at m ig h t fu n c ­
tio n  as au to in h ib ito ry  dom ain s. P e p tid es fro m  tw o  d is­
tin ct re g io n s w e re  fo u n d  to in h ib it th e C a 2+-a ctiv a te d  
h olo en zym e. T h e sam e re g io n s w e re  p re v io u sly  fo u n d  to 
b in d  calm o d u lin  (i.e. th e 5-su bu n it; D a sg u p ta , M . H o n ey­
cu tt, T ., a n d  B lu m e n th al, D. K . (1 9 8 9 ) J .  B io l . C h em . 2 6 4 , 
1 7 1 5 6 - 1 7 1 6 3 ). T h e  m ost p oten t su b stra te  a n ta g o n ist p e p ­
tid es w e re  P h K 13  (resid u es 3 0 2 - 3 2 6 ; K t = 3 0 0  nM) an d  
P h K 5  (resid u es 3 4 2 - 3 6 6 ; K t = 2 0  ^.m). B o th  p ep tid e s in ­
h ib ite d  th e h olo en zym e co m p e titive ly  w ith  re sp e ct to 
p h o sp h o ry la se  b a n d  n o n co m p e titiv e ly  w ith  re sp e ct to 
M g-A T P . W h en  th e p a tte rn  o f in h ib itio n  w ith  bo th  p e p ­
tid es p re se n t w a s  an a lyze d , in h ib itio n  w a s  o b se rv e d  to 
be sy n e rg istic  a n d  m o d e stly  co o p e ra tiv e  in d ic a tin g  th at  
th e  tw o  p ep tid e s c a n  sim u lta n eo u sly  o cc u p y  th e p ro te in  
su b stra te -b in d in g  site(s). T h ese  d a ta  a re  co n sisten t w ith  
a  m odel in  w h ic h  th e  re g io n s o f th e y -su b u n it re p r e ­
se n ted  b y  P h K 5  a n d  P h K 13  w o rk  in  co n ce rt as re g u la ­
to ry  su b d o m ain s th a t tra n sd u c e  C a 2+-in d u ced  co n fo r­
m a tio n al c h a n g e s in  th e 5-su b u n it to th e c a ta ly tic  
y-su b u n it th ro u g h  a  p se u d o su b strate  au to in h ib ito ry  
m ech an ism .
P hosphorylase k inase  is am ong th e  la rg est and  m ost complex 
of th e  p ro te in  k inase superfam ily  (review ed by P ickett-G ies 
an d  W alsh  (1)). B ecause of its  complex s tru c tu re , th e  catalytic 
activ ity  of phosphorylase k inase  is sensitive to a v arie ty  of 
effectors an d  chem ical m odifications including pH , d ivalen t 
m eta l ions, ionic s tren g th  and  com position, glycogen, calm od­
u lin , nucleosides, phosphory lation  s ta te , lim ited  proteolysis, 
an d  su b s tra te  conform ation. The su b u n it composition of phos­
phory lase k inase  is a 4fi4y 4S4, w here the  a-, i - ,  and  S-subunits 
a re  regu la to ry  an d  th e  7 -subun it harbo rs  the  cataly tic site. The
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a- and  i- su b u n its  can be phosphory lated , an d  th is  m odification 
increases th e  enzym e’s cataly tic activity , w hereas th e  S-sub- 
u n it is iden tical to calm odulin an d  confers C a2+ dependence to 
th e  enzym e’s activity. A lthough th e  a-, i - ,  and  S-subunits are 
all th o u g h t to in te rac t d irectly  w ith  th e  7 -subun it, th e  molec­
u la r  m echanism s by w hich these  regu la to ry  su b u n its  effect 
changes in  cataly tic activ ity  is no t well understood  a t p resen t.
A common m echanism  by w hich th e  catalytic activ ity  of 
m any p ro te in  k inases appears  to be reg u la ted  is th rough  a 
p seudosubstra te  au to inh ib ito ry  m echanism  (see review s by 
Soderling (2) and  Kem p and  P earson  (3)). T his in tra s te ric  form  
of regu la tion  w as firs t described in  th e  cA M P-dependent pro­
te in  k inase, b u t th e re  is now su b s tan tia l evidence th a t  th is  
m echanism  m ay also be opera ting  in  th e  cG M P-dependent 
p ro te in  k inases, m yosin ligh t chain  k inases, calm odulin-de­
p enden t type i i  k inases, th e  p ro te in  k inase-C s, as well as the 
p ro te in  p hospha tase  calc ineurin  (2, 3). The sim plest m echan is­
tic m odel for th is  form  of regu la tion  consists of two conform a­
tional s ta te s : an  au to inh ib ited  enzym atically  inactive (or less 
active) s ta te  and  a deinh ib ited  active (or m ore active) s ta te . in  
th e  au to inh ib ited  s ta te , an  au to inh ib ito ry  regu la to ry  dom ain 
occupies th e  enzym e’s substra te -b ind ing  site and  p reven ts ac­
cess of th e  p ro te in  su b s tra te  to th e  cataly tic site. u p o n  b inding 
of an  allosteric ac tiva to r to th e  regu la to ry  dom ain, a  conform a­
tional change is induced in  th e  au to inh ib ito ry  dom ain th a t 
rem oves it  from  th e  su b stra te -b ind ing  site  allow ing free access 
of th e  su b s tra te  to th e  cataly tic site.
Typically, th e  am ino acid sequence of an  au to inh ib ito ry  do­
m ain  closely resem bles th e  consensus sequence of th a t  en ­
zyme’s p referred  su b s tra te s  an d  is th e n  te rm ed  a  pseudosub­
s tra te  dom ain. in  a  num ber of cases, p ro te in  k inase 
p seudosubstra te  dom ains also con tain  phosphory latab le  re s i­
dues, an d  these  residues can be au tophosphory lated . T hus, 
identification  of p u ta tiv e  pseudosubstra te  au to inh ib ito ry  do­
m ains often en ta ils  v isual inspection  of a  p ro te in  k inase’s reg­
u la to ry  dom ain for sequences th a t  resem ble consensus sub­
s tra te  sequences. C and idate  p seudosubstra te  sequences are 
th e n  chem ically syn thesized  and  te s ted  for th e ir  ab ility  to 
in h ib it the  enzym e in  question. A lthough th e  peptide rep re ­
sen ting  an  enzym e’s p seudosubstra te  dom ain should act as a 
com petitive inh ib ito r of th e  p ro te in  (or peptide) su b s tra te , th is  
is no t alw ays th e  case (2, 3). M oreover, it  is conceivable th a t 
selecting a p u ta tiv e  p seudosubstra te  dom ain on the  basis of 
sim ilarity  to a  su b s tra te  consensus sequence could re su lt in  a 
false positive identification , particu la rly  if  th e  inh ib ito ry  capac­
ity  of th e  p u ta tiv e  syn thetic  p seudosubstra te  is low. T hus, 
positive iden tification  of p u ta tiv e  pseudosubstra te  dom ains 
m u s t be supported  by o ther d a ta  including site-d irected  m u­
tagenesis and  x-ray  crystallographic s truc tu res .
The p resen t investiga tion  is the  second phase  of a long te rm  
























regu la to ry  dom ain of th e  7-subun it of phosphorylase k inase. 
The regu la to ry  dom ain of th e  7 -subun it is defined here  as th e  
region spann ing  am ino acids 277-386  of th is  subun it. The firs t 
phase  of th is  investigative effort involved identification  of pu ­
ta tiv e  5-subunit-b inding dom ains in  the  regu la to ry  dom ain by 
p rep a rin g  a lib ra ry  of 18 overlapping syn thetic  pep tides sp an ­
n ing  res idues 277-386  an d  screening each peptide for its  ability  
to b ind  calm odulin (4). Two noncontiguous pep tides w ere iden­
tified  as being likely 5-subunit-b inding dom ains. In  the  p resen t 
study, the  sam e synthetic  pep tide lib ra ry  h as been  u sed  to 
screen for possible 7-subun it au to inh ib ito ry  dom ains. Two non­
contiguous regions in  th e  7-subun it regu la to ry  dom ain have 
been  iden tified  th a t  d isplay th e  p roperties expected of 
p seudosubstra te  au to inh ib ito ry  dom ains. These re su lts  a re  be­
ing  u sed  to d irect s tru c tu ra l s tud ies to fu r th e r elucidate  the 
m olecular m echanism s underly ing  the  regu la tion  of phospho- 
ry lase  k inase catalytic activity.
EXPERIMENTAL PROCEDURES
Synthetic Peptides—A series of 18 overlapping 25-residue peptides 
corresponding to the C-terminal 110 residues (277-386) of the 7-sub­
unit of phosphorylase kinase was synthesized and characterized as 
described by Dasgupta et al. (4). Each peptide was assigned a number 
based on its position relative to the C terminus of the 7-subunit of 
phosphorylase kinase (4). The nomenclature and sequence of each pep­
tide are shown in Table I. Shorter analogs of both PhK13 and PhK6 
were synthesized as described in Blumenthal and Krebs (5). The no­
menclature and sequence of these peptides is described in Table II. All 
of the peptides in Tables I and II were synthesized with glycine-amide 
C termini. The composition and sequence ofevery synthetic peptide was 
confirmed by quantitative amino acid analysis using a Beckman model 
6800 amino acid analyzer following acid hydrolysis and by sequence 
analysis using an Applied Biosystems Protein Sequencer model 477A.
Protein Preparation—Phosphorylase kinase was purified from rabbit 
skeletal muscle according to Cohen (12), and phosphorylase b was 
prepared according to Krebs and Fisher (6). Rabbit skeletal muscle 
myosin light chain kinase was purified as described by Takio et al. (7). 
Calmodulin was prepared from bovine testis by using the following 
sequence of steps: batchwise chromatography using DEAE-cellulose 
(DE52, Whatman Ltd.), Ca2+-dependent interaction chromatography 
(8) using phenyl-Sepharose (Sigma), and gel filtration chromatography 
(Bio-Gel A-0.5m, Bio-Rad).
Phosphorylase Kinase Assay—The rate of incorporation of 32P into 
glycogen phosphorylase b  was used to measure phosphorylase kinase 
activity. The final reaction mixtures (50 xl) for the inhibition experi­
ments contained 50 mM Tris, 50 mM ^-glycerol phosphate, pH 8.2, 1 mM 
dithiothreitol, 30 /xM phosphorylase b, 10 mM magnesium acetate, 100 
fXM calcium chloride, 1 mM 7 -32P]ATP (^300 counts/min/pmol; DuPont 
NEN), 1 xg/ml nonactivated phosphorylase kinase, and varying concen­
trations of synthetic 7-subunit peptides as indicated in the figure leg­
ends. Reactions were performed in duplicate at 30 °C, and 20-xl sam­
ples of each reaction were spotted on Whatman 3MM filter paper 
squares (1 x 1 cm) at 5 and 15 min. The squares were immediately 
immersed in 10% trichloroacetic acid, 4% sodium pyrophosphate and 
processed as described by Corbin and Reimann (9). All rates of phos­
phorylation were linear with respect to time for a t least 15 min.
Calmodulin-binding Assay— Calmodulin-binding activity was quan­
titated using a myosin light chain kinase inhibition assay as described 
previously (4). The reaction mixtures (50 xl final volume) for peptide 
inhibition experiments contained 50 mM MOPS,1  pH 7.0, 1 mM dithio- 
threitol, 130 xM substrate peptide (KKRPQRATSNVFS-amide), 10 mM 
magnesium acetate, 0.2 mM calcium chloride, 10 nM calmodulin, 1.3 nM 
skeletal muscle myosin light chain kinase, 1 mM 7 -32P]ATP (^300 
counts/min/pmol; DuPont NEN), and varying concentrations of syn­
thetic 7-subunit peptides as indicated. Reactions were performed in 
duplicate a t 30 °C, and 20-xl samples of the reaction were spotted on 
Whatman P81 phosphocellulose filter paper squares (1 x 1 cm) at 5 and
15 min. The squares were immediately immersed in 75 mM phosphoric 
acid and processed as described by Roskoski (10). All rates of 32P 
incorporation were linear with respect to time for at least 15 min.
Protein Estim ation—The concentration of myosin light chain kinase 
was determined by the method of Bradford (11), using bovine serum
1 T h e  a b b re v ia t io n  used is : M O P S , 4 -m o rp h o lin e p ro p a n e s u lfo n ic  acid .
albumin as a standard. Other protein concentrations were determined 
spectrophotometrically using values of E 280 nm,1% of 12.4 for phospho- 
rylase kinase (12) and 13.2 for phosphorylase b (13), respectively, and a 
value of E 276 nm,1% of 1.8 for calmodulin (14). Concentrations of phos- 
phorylase b are expressed in terms of molar concentrations of monomer.
Kinetic Analysis—The Ki values of the peptides that inhibited phos- 
phorylase kinase activity were determined using the following equation 
for competitive inhibition (15):
i = 1 -----=
0^
[i]




where i is the fractional inhibition observed in the presence of peptide 
inhibitor, [I] is the concentration of peptide inhibitor, [S] is the concen­
tration of phosphorylase b (30 xM) used in the reaction mixture, Km is 
the Michaelis constant for phosphorylase b (33 xM), and vt and v0 are 
the reaction rates in the presence and absence of peptide inhibitor, 
respectively. Ki values were determined by Marquardt weighted non­
linear least-squares fit estimation using the MathView Professional 
(v 1.2) program run on a Macintosh computer. The assumption of 
competitive inhibition used in these calculations was validated by ki­
netic analysis (see “Results”).
RESULTS
The purpose of th e  p re sen t investigation  w as to determ ine 
th e  possible location of au to inh ib ito ry  dom ain(s) w ith in  th e  C 
te rm in u s  of the  7 -subunit. The approach  ta k e n  w as analogous 
to th a t  previously u sed  to identify S-subunit (in tegra l calmod- 
u lin)-b inding dom ains in  th e  7-subun it. T his approach  u tilizes 
a lib ra ry  of e igh teen  overlapping 2 5 -residue syn thetic  peptides 
(the sequences an d  nom enclature a re  show n in  Table I) based  
on th e  C -term inal 110 residues of th e  7 -subunit. The lib rary  
w as constructed  in  such a w ay th a t  every 20 -residue segm ent 
betw een  residue  277 and  th e  C te rm in u s  (residue 386) of the
7 -subun it is rep resen ted  in  one of th e  18 peptides. E ach  peptide 
in  th e  lib ra ry  w as assayed  for its  ability  to in h ib it the  catalytic 
activ ity  of nonactiva ted  (nonphosphorylated) phosphorylase k i­
nase  holoenzym e. The assay  reaction  w as perform ed a t  pH  8.2 
in  th e  presence of C a2+ w ith  lim iting  concentrations of the 
su b s tra te , phosphorylase b . U n d er these  conditions, a  peptide 
th a t  can  com pete w ith  phosphorylase b  for th e  sub stra te -b in d ­
ing  site of the  enzym e will in h ib it enzym e activity. The re su lts  
of th e  assay  a re  depicted in  Table I, w here th e  K t value of each 
peptide is com pared w ith  its  previously determ ined  K D for 
calm odulin (4). The K i value of each peptide w as calcu lated  as 
described u n d er “E xperim en ta l P rocedures.” P ep tides th a t  
show ed no appreciable inh ib ition  of phosphorylase k inase  ac­
tiv ity  a t  a  concen tration  of 50 xM are ind ica ted  as hav ing  K  
values > 100 ,000  xM.
The d a ta  in  Table I ind icate  th a t  th e  7-subun it regu la to ry  
dom ain pep tides w hich exh ib it th e  m ost p o ten t inh ib ito ry  ac­
tiv ity  are  located in  two d is tinc t regions th a t  closely correspond 
to th e  regions previously show n to be involved in  S-subunit 
in te rac tions (4). M oreover, th e  pep tides from  each region th a t  
m ost strongly  inh ib ited  phosphorylase k inase  activity , PhK5 
and  PhK 13 (K  values of 20 xM an d  300 nM, respectively), are 
th e  sam e peptides from  each region th a t  w ere previously found 
to b ind  calm odulin w ith  th e  h ighes t affinity  (K D va lues of 20 
and  6.5 nM, respectively (4)). The K  va lues estim a ted  for PhK5 
and  PhK 13 are  bo th  w ith in  th e  range of va lues reported  for 
au to inh ib ito ry  dom ain  pep tides from  o ther p ro te in  k inases (40 
nM to 25 x M; see review s by S oderling  (2) and  K em p and  
P earson  (3)).
To determ ine th e  m echanism (s) by w hich PhK 5 an d  PhK13 
in h ib it th e  catalytic activ ity  of phosphorylase k inase, the  k i­
netics of inh ib ition  for each pep tide w ere analyzed  as a function 
of phosphorylase b  an d  ATP concentration . The d a ta  obtained  
w ith  PhK 13 and  PhK 5 are p lo tted  in  Fig. 1. Fig. 1A shows 
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Table I
Inhibition o f phosphorylase kinase activity by y-subunit regulatory domain peptides 
The nomenclature, residue range, sequence, and K t value for each synthetic peptide are shown. The K t values were estimated by non-linear 
curve-fitting as described under “Experimental Procedures.” Dissociation constants for calmodulin binding are also indicated for each peptide (4).
Name Residues Sequence Calmodulinbinding
Substrate
antagonism
Kd, nM K;, nM
PhK1 362-386 QQQNRAALFENTPKAVLFSLAEDDY (>50,000) (> 10i0,000)
PhK2 357-381 WVKKGQQQNRAALFENTPKAVLFSL 4,700 (> 100 ,000)
PhK3 352-376 RIYGHWVKKGQQQNRAALFENTPKA 794 (> 100 ,000)
PhK4 347-371 DAYAFRIYGHWVKKGQQQNRAALFE 190 50,000
PhK5 342-366 LRRLIDAYAFRIYGHWVKKGQQQNR 20 20,000
PhK6 337-361 YALRPLRRLIDAYAFRIYGHWVKKG 36 33,000
PhK7 332-356 VIRDPYALRPLRRLIDAYAFRIYGH 430 (> 100 ,000)
PhK8 327-351 VTREIVIRDPYALRPLRRLIDAYAF (>50,000) (> 100 ,000)
PhK9 322-346 RRVKPVTREIVIRDPYALRPLRRLI (>50,000) (> 100 ,000)
PhK10 317-341 IYYQYRRVKPVTREIVIRDPYALRP (>50,000) (> 100 ,000)
PhK11 312-336 LASVRIYYQYRRVKPVTREIVIRDP (>50,000) (> 100 ,000)
PhK12 307-331 ICLTVLASVRIYYQYRRVKPVTREI 14 2,000
PhK13 302-326 GKFKVICLTVLASVRIYYQYRRVKP 6.5 300
PhK14 297-321 HFSPRGKFKVICLTVLASVRIYYQY 35 2,000
PhK15 292-316 VEEVRHFSPRGKFKVICLTVLASVR 56 2,000
PhK16 287-311 FQQYVVEEVRHFSPRGKFKVICLTV 640 10,000
PhK17 282-306 LAHPFFQQYVVEEVRHFSPRGKFKV (>50,000) (> 100 ,000)









Fig. 1. D ouble-reciprocal p lo ts o f phosphory lase k inase  inh ib itio n  by PhK5 and  PhK13. Panels A  and B  show double-reciprocal plots 
of phosphorylase kinase inhibition by the indicated concentrations of PhK13 as a function of phosphorylase b and ATP concentration, respectively. 
Panels C and D show the corresponding plots for inhibition by PhK5. The concentration of ATP used in panels A  and C was 1 mM. The concentration 
of phosphorylase b used in panels B  and D was 30 xM. Other details of the reaction conditions are given under “Experimental Procedures.”
phosphorylase b concen tration  ob tained  w hen nonactivated  
phosphorylase k inase  w as assayed  in  th e  p resence of C a2+ (100 
XM), a fixed concentration  of ATP (1 mM), and  various fixed
concentrations of PhK 13 (0 .3-3  xm). The in tersec tion  of th e  
double-reciprocal plots for th e  various concentrations of PhK 13 























Fig. 2. D eterm ination  of K t va lues for PhK13 an d  PhK5 from  
rep lo ts of slope versu s  p ep tid e  concen tra tion . Slopes of lines de­
termined from plots shown in Fig. 1, A  and C, were replotted as a 
function of PhK13 and PhK5 concentration, respectively, to determine 
K  values for PhK5 and PhK13 with respect to phosphorylase b.
PhK 13 acts as a com petitive inh ib ito r of phosphorylase b. A 
rep lo t of th e  slopes in  Fig. 1A as a function  of PhK 13 concen­
tra tio n  (show n in  Fig. 2A) yields an  e s tim a te  of 300 nM for th e  
value  of th e  K i,  th e  sam e value  as e stim a ted  by non-linear 
curve-fitting  procedures (Table I). D ouble-reciprocal plots of 
phosphorylase k inase  activ ity  as a function  of A TP concen tra­
tion, a t  various fixed concentrations of PhK 13, and  a t  a fixed 
concentration  of phosphorylase b (30 .^m) a re  show n in  Fig. 1B. 
In  th is  case, th e  double-reciprocal plots in te rsec t on th e  
[ATP]-1 -axis ind ica ting  th a t  PhK 13 acts as a pu re  noncom pet­
itive inh ib ito r w ith  respect to ATP (15).
T he double-reciprocal plots show n in  Fig. 1 ind ica te  th a t  th e  
peptide PhK 5 inh ib its  th e  cata ly tic  activ ity  of phosphorylase 
k inase  in  a m an n er sim ilar to PhK 13. Fig. 1C shows a series of 
plots in  double-reciprocal fo rm at w here th e  x  axis rep resen ts  
th e  reciprocal of th e  concentration  of phosphorylase b , th e  y  
axis rep resen ts  th e  reciprocal o f th e  reaction  ra te , and  each line 
rep resen ts  d a ta  ob tained  a t  th e  ind ica ted  concentration  of 
PhK 5. As in  th e  case of PhK 13, th e  lines converge on th e  y  axis 
a t  [phosphorylase b ] - 1  = 0 , ind ica ting  com petitive inh ib ition  
by PhK 5 w ith  respec t to phosphorylase b. A rep lo t of th e  slopes 
of th e  lines in  Fig. 1C as a function  of PhK 5 concentration  (Fig. 
2B) yields a K  va lue for PhK 5 of 20 ^M, th e  sam e value 
obtained  by non-linear cu rve-fitting  procedures (Table I). The 
double-reciprocal plots show n in  Fig. 1D, w here th e  ra te  of 
phosphorylase k inase  activ ity  is p lo tted  as a function  of ATP 
concentration  a t  various fixed concentrations o fP hK 5, ind icate  
th a t  PhK 5 exhib its hyperbolic (partia l) m ixed-type inh ib ition  
w ith  respec t to ATP (15). A hyperbolic m ixed-type inh ib ition
p a tte rn  ind ica tes th a t  PhK 5 causes a change in  th e  K m for ATP, 
as well as a change in  th e  V max, and  is th u s  ac ting  as a p a rtia l 
noncom petitive inh ib ito r. In te rsec tion  of th e  double-reciprocal 
p lots below th e  x  axis (1/[ATP]) ind ica tes th a t  PhK 5 causes a 
decrease in  th e  K m for A TP (15). Secondary rep lo ts (no t shown) 
of th e  reciprocal of th e  y  axis in te rcep t (1/A in tercep t) as a 
function  of th e  reciprocal of PhK 5 concentration  ind ica te  th a t  
b ind ing  of PhK 5 to phosphorylase k inase  decreases th e  K m for 
ATP by abou t 2-fold (a  = 0.47) and  reduces Vmax by abou t 5-fold 
(ft = 0.18). A pu re  noncom petitive inh ib ito r w ould have no 
effect on K m (a  = 1) and  w ould to ta lly  block ca ta lysis w hen 
bound to th e  enzym e (ft = 0).
T hus, PhK 5 and  PhK 13 bo th  ac t as com petitive inh ib ito rs of 
phosphorylase b , and  bo th  are  noncom petitive inh ib ito rs of 
ATP, a lthough  un like  PhK 13, PhK 5 is no t a pu re  noncom pet­
itive inh ib ito r of ATP. The p a tte rn  of inh ib ition  seen  w ith  PhK 5 
and  PhK 13 is consisten t w ith  th e  phosphory lation  reaction  
m echanism  being  a sequen tia l rap id -equ ilib rium  random  Bi-Bi 
m echanism , as previously reported  (16 -18). The p a tte rn  of 
inh ib ition  seen h ere  is sim ilar to w h a t w as reported  u sing  
syn thetic  peptides b ased  on th e  pu ta tiv e  au to inh ib ito ry  dom ain 
of skele ta l m uscle m yosin ligh t chain  k inase, an  enzym e th a t  
also exhibits a rap id -equ ilib rium  random  Bi-Bi m echanism  (19, 
20). Those pep tides inh ib ited  m yosin ligh t chain  k inase  com­
petitively  w ith  respec t to phosphate  acceptor su b s tra te  and  
noncom petitively w ith  respect to ATP (21). As in  th e  case of 
m yosin lig h t chain  k inase  (2 1 ), add ition  of a m olar equ ivalen t 
o f calm odulin  re la tive  to inh ib ito r pep tide w as able to overcome 
inh ib ition  (d a ta  n o t shown).
T he finding th a t  bo th  PhK 5 and  PhK 13 a re  com petitive 
inh ib ito rs of phosphorylase b phosphory lation  ra ises  th e  ques­
tion  as to w hether th e  pep tides can  ac t synergistically  or 
w hether th e ir  inh ib ition  is m u tu a lly  exclusive. To answ er th is 
question , th e  activ ity  of phosphorylase k inase  inh ib ited  by 
m ix tu res  of PhK 5 and  PhK 13 w as analyzed graphically  using  
D ixon plots, as show n in  Fig. 3. In  Fig. 3A, th e  reciprocal of th e  
reaction  ra te  is p lo tted  as a function  of PhK 13 concentration  a t 
various fixed concentrations of PhK 5. The sam e d a ta  a re  show n 
in  Fig. 3B, b u t in  th is  p lo t th e  reciprocal of th e  reac tion  ra te  is 
p lo tted  as a function  of PhK 5 concentration , w ith  each  line 
rep resen tin g  a d ifferen t concen tration  of PhK 13. In  Fig. 3, A  
and  B , th e  lines converge ind ica ting  th a t  inh ib ition  by PhK 5 
and  PhK 13 w ith  respect to phosphorylase b is synergistic  (15). 
P a ra lle l lines w ould have ind icated  th a t  th e  two peptides in ­
h ib ited  th e  enzym e in  a m u tua lly  exclusive m anner. The po in t 
a t  w hich th e  lines converge in  each  p lo t provides inform ation  
reg ard in g  th e  degree of cooperativity  betw een  th e  two inh ib i­
tors. The x  axis v a lue  w here th e  lines converge is equal to ~ a K t, 
w here K i is th e  inh ib ition  co n stan t for th e  inh ib ito r th a t  w as 
v aried  and  a  is th e  coefficient of cooperativity. W hen a  = 1, i t  
ind ica tes a lack  of cooperativity  betw een  th e  inh ib ito rs. W hen 
a  >  1 , i t  ind icates th a t  inh ib ito r b ind ing  is negatively  cooper­
ative, w hereas w hen a  <  1 , i t  ind ica tes th a t  inh ib ito r b ind ing  is 
positively cooperative. The values of a  calcu lated  from  Fig. 3, A  
and  B, w ere 0.35 and  0.67, respectively, based  on th e  previously 
determ ined  K  va lues for PhK 13 and  PhK 5 (0.3 and  20 iXM, 
respectively; cf. Table I and  Fig. 2). T hese two es tim ates  for a  
a re  in  reasonab le  ag reem en t w ith  each  o ther and  ind ica te  th a t  
th e  sim ultaneous b ind ing  of PhK 5 and  PhK 13 to th e  phospho- 
ry lase  b su bs tra te -b ind ing  site  shows m odest positive cooper- 
a tiv ity  (0.3 <  a  <  0.7). T hese values ind icate  th a t  th e  b ind ing  
of one peptide to th e  enzym e enhances th e  b ind ing  of th e  o ther 
pep tide by abou t a factor of 2. Synergistic inh ib ition  betw een  
PhK 5 and  PhK 13 also ind ica tes th a t  phosphorylase k inase  
contains a d is tinc t b ind ing  site  for each  peptide. T aken  to ­























itors of phosphorylase b suggests th a t  phosphorylase k inase  
m ay have tw o d is tinc t b ind ing  sites for phosphorylase b.
To b e tte r  define th e  d e te rm in an ts  in  PhK 5 and  PhK 13 c rit­
ical for au to inh ib ito ry  function versus  S -subunit in terac tion , a 
series of tru n c a te d  pep tides w as p rep ared  and  assayed  for 
phosphorylase k inase  inh ib ito ry  activ ity  an d  calm odulin  b ind ­
ing activity. B ecause s ta n d a rd  solid-phase peptide syn thesis 
proceeds from  th e  carboxyl te rm in u s  tow ard  th e  am ino te rm i­
nus of th e  peptide, a  series of tru n ca tio n  pep tides w hich share  
a common carboxyl te rm in u s  can  be easily  p rep ared  by rem ov­
ing aliquots of peptide res in  a t  d ifferen t s tages du ring  th e  
synthesis. T able I I  show s th e  sequences, calm odulin-binding 
affinity, e s tim a ted  K i for au to inh ib ition , an d  nom enclature for 
th e  e igh t peptides th a t  w ere synthesized . The sequences of 
PhK 5, PhK 6 , an d  PhK 13 an d  th e ir  respective d a ta  are  also 
p resen ted  in  T able I I  for purposes of com parison.
B ecause PhK 5 and  PhK 6  exh ib it sim ila r K i va lues for au to ­
inh ib ition  an d  sim ilar affin ities for calm odulin, i t  is reasonable  
to propose th a t  th e  m in im um  essen tia l d e te rm in an ts  for au to ­
inh ib ition  and  S-subun it b ind ing  function for th is  regu la to ry  
subdom ain  w ould be con tained  in  th e  sequence common to both  
peptides. T his core sequence is rep resen ted  by th e  peptide 
te rm ed  PhK 6E  w hich h a s  th e  sam e am ino te rm in u s  as PhK 5 
and  th e  sam e carboxyl te rm in u s  as PhK 6 , b u t w hich lacks th e  
carboxyl-term inal sequence of PhK 5 (Gln-Gln-Gln-Asn-Arg) 
and  th e  am ino-term inal sequence of PhK 6  (Tyr-Ala-Leu-Arg- 
Pro). T he K i va lue  for au to inh ib ition  w ith  P hK 6E  is th e  sam e as 
th a t  for PhK 6  and  approxim ately  50% h igher th a n  for PhK5, 
suggesting  th a t  th e  sequence Tyr-A la-Leu-Arg-Pro (337-341) 
does no t contain  d e te rm in an ts  e ssen tia l for au to inh ib ition , 
w hereas d e te rm in an ts  in  th e  sequence G ln-G ln-Gln-Asn-Arg 
(362-366) con tribu te  m odestly  to  th e  K i value. W ith  reg ard  to 
its  affin ity  for calm odulin, PhK 6E  b inds calm odulin 5-fold 
w eaker th a n  P hK 6 an d  10-fold w eaker th a n  PhK 5, suggesting  
th a t  th e  sequences Tyr-A la-Leu-Arg-Pro (337-341) an d  Gln- 
G ln-G ln-Asn-Arg (362-366) bo th  con tribu te  significantly  to th e  
in te rac tions of th e  7 -subun it w ith  th e  S-subunit. The peptide 
P hK 6D, w hich is tw o residues sh o rte r a t its  am ino te rm in u s 
th a n  P hK 6E, h ad  a  K i va lue  for au to inh ib ition  th a t  w as only 
about 30% g rea te r th a n  P hK 6E, b u t bound calm odulin about
8 -fold w eaker, ind ica ting  th a t  Leu-A rg (342-343) con tribu tes 
significantly  to  S-subun it b inding, b u t is only m arg inally  im ­
p o rta n t for au to inh ib ition . S im ila r effects on affin ity  for cal­
m odulin  an d  K i for au to inh ib ition  w ere observed w hen th e  
sequence A rg-Leu-Ile (344-346) w as rem oved on going from  
P hK 6D to  P hK 6C. T he pep tide P hK 6B, w hich is th re e  residues 
sh o rte r th a n  P hK 6C, h a s  no detec tab le  au to inh ib ito ry  activ ity  
a t  concen trations as h igh  as 50 xM, b u t still re ta in s  th e  ab ility  
to b ind  calm odulin w ith  low affinity  (KD = 20 xM). T he peptide 
P hK 6A, w hich is tw o residues sh o rte r th a n  P hK 6B, h a s  no 
detec tab le  au to inh ib ito ry  activ ity  or affin ity  for calm odulin. 
T hus, it appears  th a t  th e  sequence rep resen ted  by PhK 5 is th e  
sh o rte s t sequence in  th e  C -term inal regu la to ry  dom ain of th e  
7 -subun it w ith  op tim al au to inh ib ito ry  activity. The differences 
in  affinity  for calm odulin observed betw een  P hK 6 an d  P hK 6E  
suggest th a t  add ing  th e  sequence Tyr-A la-Leu-Arg-Pro (337­
341) to  th e  am ino te rm in u s  of PhK 5 to  form  a 30-residue 
peptide (337-366) m igh t increase th e  affinity  for calm odulin 
above th a t  seen  w ith  PhK 5, b u t th is  idea h as no t been tested .
The stud ies w ith  peptides based  on PhK 13 included two 
tru n c a te d  pep tides th a t  w ere sh o rte r th a n  PhK 13 and  one 
peptide th a t  w as one residue longer a t  its  am ino te rm in u s  th a n  
PhK 13 (Table II). T he longer peptide PhK 13C (301-326) had  
A rg301 added  to  its  am ino te rm in u s  and  show ed a 6.5-fold 
h igher affin ity  for calm odulin th a n  PhK 13 and  a K i for au to in ­
h ib ition  th a t  w as 33% low er th a n  for PhK 13. T hese d a ta  sug-
Fig. 3. In h ib ition  of phosphory lase k in ase  ac tiv ity  by m ix­
tu re s  of PhK5 an d  PhK13. Phosphorylase kinase activity was deter­
mined at the indicated concentrations of PhK5 and PhK13 and repre­
sented in Dixon plots. Panel A  depicts the effects on phosphorylase 
kinase activity of fixed concentrations of PhK5 as a function of PhK13 
concentration. The same data are replotted in panel B , but as a function 
of PhK5 concentration at fixed concentrations of PhK13. The concen­
trations of phosphorylase b and ATP used in these reactions were 30 xM 
and 1 mM, respectively. Other assay conditions are detailed under 
“Experimental Procedures.”
gest th a t  th is  single A rg residue  is im p o rtan t for bo th  S-subunit 
in te rac tions an d  au to inh ib ition . R em oving th e  six residue  se­
quence A rg-Gly-Lys-Phe-Lys-Val (301-306) from  th e  am ino 
te rm in u s  of PhK 13 re su lted  in  a 10-fold decrease in  affinity  for 
calm odulin and  less th a n  a  2-fold increase in  th e  K i for au to ­
inh ib ition  re la tive  to PhK 13. Rem oving an  add itional five re s ­
idues, Ile-Cys-Leu-Thr-V al (307-311), re su lted  in  a 15-residue 
pep tide (312-326) th a t  h ad  no detec tab le  affinity  for calm odu­
lin  and  no detectable au to inh ib ito ry  activity. T hese d a ta  sug ­
gest th a t  th e  sequence Ile-Cys-Leu-Thr-V al (307-311) is essen ­
tia l for bo th  au to inh ib ition  and  S-subun it in teractions. 
C onsis ten t w ith  th is  proposal is th e  finding th a t  a ll of th e  PhK  
peptides th a t  con tain  th is  sequence (PhK 12 th ro u g h  PhK 16) 
have au to inh ib ito ry  and  calm odulin b ind ing  activity , w hereas 
pep tides im m ediately  flank ing  these  pep tides are  lacking in 
bo th  functional activ ities (Table I).
DISCUSSION
U sing  a lib ra ry  of overlapping syn thetic  pep tides based  on 
th e  regu la to ry  dom ain of th e  7 -subun it of phosphorylase k i­
nase , tw o d is tinc t noncontiguous regions, residues 302-326 
(PhK 13) and  342-356  (PhK5), have been iden tified  as being 
p u ta tiv e  p seudosubstra te  au to inh ib ito ry  dom ains. Pep tides 
from  each of th ese  two regions inh ib ited  ca ta ly tic  activ ity  of 
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Table II
Effect o f peptide length on calmodulin binding and inhibition o f phosphorylase kinase activity by y-subunit regulatory domain peptides 
The peptide name, residue range, sequence, and Ki value for each synthetic peptide are shown. The Ki values and calmodulin dissociation 
constants were estimated by non-linear curve-fitting as described under “Experimental Procedures.”
Name Residues Sequence Calmodulinbinding
Substrate
antagonism
Kd, nM Ki, nM
PhK5 342-366 LRRLIDAYAFRIYGHWVKKGQQNR 20 20,000
PhK6A 352-361 RIYGHWVKKG (>50,000) (> 100 ,000)
PhK6B 350-361 AFRIYGHWVKKG 20,000 (> 100 ,000)
PhK6C 347-361 DAYAFRIYGHWVKKG 10,000 45,000
PhK6D 344-361 RLIDAYAFRIYGHWVKKG 1,600 40,000
PhK6E 342-361 LRRLIDAYAFRIYGHWVKKG 200 30,000
PhK6 337-361 YALRPLRRLIDAYAFRIYGHWVKKG 36 33,000
PhK13 302-326 GKFKVICLTVLASVRIYYQYRRVKP 6.5 300
PhK13A 312-326 LASVRIYYQYRRVKP (>50,000) (> 100 ,000)
PhK13B 307-326 ICLTVLASVRIYYQYRRVKP 75 500
PhK13C 301-326 RGKFKVICLTVLASVRIYYQYRRVKP 1 200
£,v;
Fig. 4. Amino ac id  sequence a lignm ent o f phosphory lase 6(2-87), an d  p u ta tiv e  phosphory lase k inase  p seu d o su b stra te  autoin- 
h ib ito ry  dom ains from  th e  y-subunit(296-377) an d  th e  0-subunit(296-377). Amino acid identities are indicated by (|), close chemical 
similarities by (:), and distant similarities by (•). The sequences of PhK5 and PhK13 are underlined in bold and the interconvertible Ser14 of 





p h a te  acceptor su b s tra te , phosphorylase b, and  noncom peti­
tively w ith  respec t to th e  phosphate  donor su b s tra te , Mg\ATP. 
M oreover, pep tides from  th e  two regions inh ib ited  cata ly tic  
activ ity  in  a synergistic m anner, ind ica ting  th a t  bo th  pep tides 
can b ind  th e  y -subun it a t  the  sam e tim e. The inh ib ito ry  capac­
ity  of these  pep tides could be overcome by th e  add ition  of a 
m olar excess of calm odulin, consisten t w ith  th e ir  previously 
being iden tified  as calm odulin(S-subunit)-binding dom ains (4). 
This appears  to be th e  f irs t exam ple of a calm odulin-regu lated  
p ro te in  k inase  w ith  m ultip le  noncontiguous synergistic auto- 
inhibitory/calm odulin-binding subdom ains.
R eim ann et al. (22) f irs t suggested  th a t  th e  C -term inal 110 
am ino acids of th e  y -subun it (residues 277-386) m igh t consti­
tu te  th e  regu la to ry  dom ain of phosphorylase k in ase . S ubse­
quently , lim ited  proteolysis (23) and  genetically  engineered  
tru n ca tio n  m u ta n ts  (24, 25) of th e  y -subun it w ere used  to show 
th a t  residues 298 -386  contain  an  au to inh ib ito ry  dom ain. The 
two p u ta tiv e  au to inh ib ito ry  dom ain sequences identified  in  the 
p re sen t study, 302-326  (PhK13) and  342-356  (PhK5), a re  both  
located in  th is  region of th e  y -subun it. N e ith e r of these  se­
quences corresponds to th e  pu ta tiv e  p seudosubstra te  dom ain 
proposed by K em p and  P earson  (3) who suggested  th a t  residues 
332-353 m igh t rep re sen t th e  p seudosubstra te  dom ain based  
upon inspection of th e  y -subun it sequence. M oreover, th e  pep­
tide con tain ing  th is  la t te r  sequence, PhK 7 (residues 332-356), 
showed v irtu a lly  no inh ib ito ry  activ ity  in  th e  p re sen t study  
(Table I).
B ecause PhK 5 and  PhK 13 act as com petitive inh ib ito rs of 
phosphorylase b , some sequence sim ila rity  betw een  these  pep­
tides and  phosphorylase m igh t be expected. Sequence align ­
m en t of phosphorylase w ith  PhK 5 and  PhK 13 reveals th a t  both  
pep tides con tain  sh o rt s tre tches of sequence th a t  closely resem ­
ble the  sequence of phosphorylase (Fig. 4). The two regions of 
h ighest sequence sim ila rity  correspond closely to th e  regions 
requ ired  for su b s tra te  inh ib ito ry  activ ity  based  on th e  d a ta  
show n in  T ables I and  II. I t  is p a rticu la rly  no tew orthy  th a t  a 
m ajor portion  of PhK 13 shows sequence sim ila rity  w ith  the 
sequence su rround ing  S er14  in  phosphorylase b , th e  phospho-
ry la tion  site  in  phosphorylase b .
The m ost sign ifican t sequence sim ila rity  betw een  PhK 13 
(Lys303 to A rg323) and  phosphorylase b (Lys9 to Lys29) spans 21 
am ino acids. T his sequence is only found in  its  en tire ty  in  
PhK 13, th e  pep tide w ith  th e  low est K t value (0.3 x m ) of the 
inh ib ito ry  pep tides in  the  region spann ing  PhK 12 th rough  
PhK 16 (Table I). The sequence Ile-Cys-Leu-Thr-V al appears  to 
be especially  im p o rtan t for inh ib ition  because i t  is sh ared  by all 
of th e  inh ib ito ry  pep tides in  th is  group and  because tru n ca tio n  
pep tides based  on PhK 13 th a t  lack  th is  sequence are  n o t in ­
hib ito ry  (Table II). In teresting ly , th e  corresponding pentapep- 
tide from  phosphorylase b is a  com petitive inh ib ito r w ith  a  K i 
value of abou t 6 mM (26), and  Ile-Ser-Val-Arg-Gly-Leu (phos­
phorylase b (13-18)) is th e  sh o rte s t syn thetic  pep tide su b s tra te  
th a t  can be phosphory lated  by phosphorylase k inase  (16). 
O th e r im p o rtan t d e te rm in an ts  of su b s tra te  recognition (26) 
which are  iden tica l in  th e  a lignm en t of PhK 13 and  phospho-
rylase b include Lys9(Lys303), Lys1 1 (Lys305), Ile13 (Ile307), and
L eu 18(Leu312). U sing y-subunit(1-300), a  tru n ca ted  form of the 
y -subun it th a t  lacks a regu la to ry  dom ain, H uang  e t al. (27) 
recen tly  dem onstra ted  th a t  G lu 1 1 1  and  G lu 154 a re  involved in  
b ind ing  peptide su b s tra te s  a t  th e ir  P-3 and  P-2 positions, re ­
spectively. M uta tions of these  residues increased  th e  K i value 
for PhK 13 by 14- and  8-fold, respectively, ind ica ting  th e ir  in ­
volvem ent in  b ind ing  PhK 13, as well as pep tide substra tes . 
Thus, th e  sequence corresponding to PhK 13 (residues 302-326) 
appears  to rep re sen t a proto typical p seudosubstra te  dom ain 
th a t  reg u la te s  th e  ca ta ly tic  activ ity  of phosphorylase k inase  by 
preven ting  th e  phosphory lation  site  of phosphorylase b access 
to th e  ca ta ly tic  site .
The ability  of PhK 5 to ac t as a com petitive inh ib ito r of 
phosphorylase k inase  holoenzym e (Fig. 1) and  its  sequence 
sim ilarity  to a region of phosphorylase b approxim ately  50 
residues C -term inal to S e r 14 (Fig. 4) suggest th a t  phosphoryl- 
ase b m ay  have a m ajor b ind ing  site  on th e  holoenzym e in 
addition  to th e  b ind ing  site  th a t  recognizes th e  sequence 
around  S e r 14 and  th a t  th is  secondary b ind ing  site is also in ­






















h ig h est sim ilarity  to phosphorylase is Arg-Ile-Tyr-G ly-His-Trp- 
Val-Lys (residues 352-359) w hich aligns w ith  H is-Leu-Val-Gly- 
A rg-Trp-Ile-A rg (residues 6 2 -69 ) in  phosphorylase (Fig. 4). 
T his sequence is sh a red  by PhK 4, PhK 5, and  P hK 6 , th e  only 
inh ib ito ry  pep tides in  th is  region of th e  7 -subun it (Table I). I t is 
in te re s tin g  to note th a t  G raves and  co-workers have show n 
th a t  syn thetic  pep tides corresponding to th e  sequence of phos- 
phory lase b  a round  its  phosphorylation  site a re  poor su b s tra te s  
com pared to th e  in tac t p ro te in  (26) and  th a t  longer a CN Br 
fragm en t of phosphorylase b  corresponding to residues 1-99 
(16) exh ib ited  a  K m value in te rm ed ia te  betw een  th a t  of th e  
syn thetic  pep tides and  native  phosphorylase b . The d a ta  ob­
ta in ed  in  th e  p resen t study  show ing th a t  PhK 5 inh ib its  phos- 
phory lase k inase  activ ity  synergistically  w ith  PhK 13 (Fig. 3) 
provides fu r th e r evidence th a t  th e re  are  a t  leas t two distinct 
su b s tra te  b ind ing  sites for phosphorylase b  an d  th a t  bo th  of 
these  su b s tra te  b ind ing  sites m igh t be u sed  by au to inh ib ito ry  
elem en ts in  th e  7-subun it to regu la te  th e  catalytic activ ity  of 
phosphorylase k inase. Inspection  of th e  several x-ray  crystal 
s tru c tu re s  of phosphorylase (28, 29) show th a t  th e  phosphoryl­
a tion  site  an d  th e  PhK 5-like region of phosphorylase are  re la ­
tively close to one an o th e r on th e  surface of th e  pro tein , adding 
support to th e  idea th a t  these  two regions of phosphorylase 
m igh t be sim ultaneously  involved in  in te rac tions w ith  phos- 
phory lase k inase.
The k inetics of inh ib ition  seen w ith  PhK 5 and  PhK 13 in  the 
p re sen t study  using  phosphorylase k inase  holoenzym e are  in  
basic ag reem ent w ith  s tud ies done using  a  7-subun it tru n c a ­
tion  m u ta n t, 7-subunit(1 -300), w hich rep re sen ts  a m inim al 
7 -subun it cataly tic su b u n it th a t  lacks calm odulin-binding and  
au to inh ib ito ry  p seudosubstra te  dom ains (27). In  th e  stud ies 
w ith  7-subunit(1 -300), PhK 5 and  PhK 13 w ere bo th  found to be 
p o ten t inh ib ito rs, a lthough  bo th  PhK 5 and  PhK 13 w ere slightly  
less po ten t (3-6-fold) inh ib ito rs of 7-subunit(1 -300) th a n  th e  
holoenzym e. The p a tte rn s  of inh ib ition  of PhK 5 and  PhK 13 
tow ard  7-subunit(1 -300) w ere iden tical to those seen in  th e  
p re sen t study  using  holoenzym e, except th a t  PhK 5 w as a  non­
com petitive inh ib ito r w ith  regard  to phosphorylase b  (as com­
p ared  to being a com petitive inh ib ito r in  th e  case of th e  holoen- 
zyme) and  a sim ple noncom petitive inh ib ito r w ith  regard  to 
A TP (as com pared to being a  m ixed noncom petitive inh ib ito r of 
th e  holoenzym e). B ecause th e  7-subunit(1 -300) rep resen ts  a 
m in im al 7 -subun it catalytic su b u n it th a t  lacks th e  m any in ter- 
an d  in tra su b u n it in te rac tions p resen t in  th e  holoenzym e, it  is 
no t unexpected  th a t  some differences in  potency and  p a tte rn s  
of inh ib ition  m igh t be observed for PhK 5 and  PhK 13 betw een 
th e  two form s of th e  enzym e.
In  co n trast to th e  findings of th e  p resen t study, N ew sholm e 
e t al. (30) have concluded th a t  n e ith e r PhK 5 nor PhK 13 are  
likely to rep resen t p seudosubstra te  dom ains because bo th  pep­
tides appeared  to be noncom petitive inh ib ito rs of phosphoryl- 
ase b  in  th e ir  experim ents. H owever, th e  k inetic  d a ta  obtained 
by these  investiga to rs for PhK 13 could no t conclusively dis­
crim inate  betw een  com petitive and  noncom petitive inh ib ition  
because of problem s of solubility a t  h igh  peptide concentra­
tions. No such solubility  problem s w ere encountered  in  th e  
experim en ts described here  or in  o ther s tud ies involving re la ­
tively h igh  concentrations of PhK 5 and  PhK 13 (27, 31). The 
differences in  re su lts  obtained  cannot be read ily  explained b u t 
m igh t be due to differences in  assay  conditions or th e  q u a lity  of 
pep tides u sed  in  th e  two stud ies. PhK 5 in  p a rticu la r h a s  sev­
e ra l am ino acids th a t  a re  especially sensitive to incom plete side 
chain  deprotection  and  m odification during  syn thesis, cleav­
age, and  purification . All of th e  pep tides u sed  in  th e  p res­
e n t study  w ere subjected  to pep tide sequence analysis, q u an ti­
ta tiv e  am ino acid analysis, and  UV spectra l analysis.
In  add ition  to th e  two p u ta tiv e  au to inh ib ito ry  dom ains in  the 
7 -subun it, Sanchez and  C arlson  (32) have recen tly  reported  
th a t  residues 4 2 0 -4 3 6  in  th e  ^ -su b u n it of phosphorylase k i­
nase  m ay constitu te  a po ten tia l au to inh ib ito ry  dom ain. The 
proposed sequence alignm en t re la tive  to th e  phosphorylation  
site in  phosphorylase b is show n in  Fig. 4. K inetic analysis of a 
syn thetic  peptide based  on th e  ^ -su b u n it 4 2 0 -4 3 6  sequence 
ind ica ted  a p a tte rn  of inh ib ition  th a t  w as com petitive w ith  
respect to phosphorylase b (K i = 921 xM) an d  uncom petitive 
w ith  respect to ATP using  th e  S-7  enzym e complex. How these 
various au to inh ib ito ry  dom ains m igh t in te rac t in  th e  holoen- 
zyme rem ains to be answ ered. O ne possibility  is th a t  each 
dom ain acts independently  to in h ib it phosphorylase b binding. 
A nother possibility  is th a t  th e  dom ain on th e  ^ -su b u n it acts by 
inducing conform ational changes in  th e  regions corresponding 
to PhK 5 and  PhK 13, w hich in  tu rn  a lte r  catalytic activity. 
E lucidation  of the  precise m echanism s by w hich these  various 
au to inh ib ito ry  dom ains effect changes in  th e  enzym atic activity  
of phosphorylase k inase  w ill requ ire  de ta iled  s tru c tu ra l stud ies 
involving a v arie ty  of approaches including th e  use of syn­
thetic  peptide analogs, site-d irected  m utagenesis, an d  x-ray 
crystallography.
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